Why the urgency for Deep and Frequent Phenotyping study? @medicalresearchcouncil
Why the urgency for Deep and Frequent Phenotyping study?  @medicalresearchcouncil
Uploaded August 2016 | Updated September 2026, 1 week ago
A new multimillion pound study, which will see the most thorough and rigorous series of tests to detect Alzheimer’s disease ever performed on volunteers, has been announced. The Deep and Frequent Phenotyping study is funded by the National Institute for Health Research (NIHR) and the Medical Research Council (MRC) and hopes to dramatically improve the success rate of clinical trials for treatments into Alzheimer’s disease.

Here, Trial's manager, Jennifer Lawson, explains the urgent need for diagnosis.

News story: mrc.io/2b6i7OH
Why the urgency for Deep and Frequent Phenotyping study?Interview with Mike OwenCelebrating 100 Years of Life-Changing | Discoveries Antibacterials From Fleming to Dowson and RoperMRC Festival: Getting out of the labFEAST Clinical Trial | Anatomy of a Clinical Trial (Update)Superhero Adam Roberts vs SuperbugsSmartphone app supporting people with schizophrenia and bipolar disorderMax Perutz Science Writing Award 2012MRC Impact Prize 2022 Awards CeremonyWhy world leaders must take action to achieve #NetZero: Mortala Ndow, MRC Unit The GambiaMRC Festival scientists in the supermarketN-ALIVE Giving the Naloxone | How to Respond to a Suspected Overdose
Medical Research Council |

Why the urgency for Deep and Frequent Phenotyping study?

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER